Patient-Derived Organoids Functionally Stratify Epithelial Ovarian Cancer into Clinically Relevant Chemotherapy Response Phenotypes
Shruthi Ragothaman, Raghuveer Reddy, Shelma Cheeran Sajan, Leah Achsah John, Viamaya Biju, Y Vipulachandra, Satish Sankaran, Rohit Raghunath Ranade, Smitha P.K.
This study uses patient-derived organoids to classify ovarian cancer into chemotherapy response phenotypes, showing they correlate with clinical outcomes and traditional biomarkers.
bioRxiv · Jul 7, 2026 · PreprintCancer Biology